On May 28, 2026, Medbolide Pharmaceutical JSC attended a scientific seminar hosted by the Department of Neurology at Military Central Hospital. The seminar was attended by doctors and nurses from the department and was chaired by the Department Head, Dr. Nguyen Hong Quan.
At the session, a representative from Medbolide introduced three products to the department:
1. LERFOZI (active ingredient: Trazodone 50mg/100mg) offers the outstanding benefits of Trazodone—a new-generation active ingredient for treating depression and insomnia:
- Fewer side effects
- Effective for all types of insomnia
- Included in treatment guidelines from reputable organizations: APA, NICE
2. FLIBGA (active ingredient: Meclizine 25 mg) with the superior benefits of Meclizine – An effective solution for the treatment of acute and severe vestibular disorders:
- Equivalent efficacy to Diazepam
- Active ingredient approved by the FDA since 1957
- First-line treatment for severe vestibular disorders
- Reduces dizziness and nausea within the first 7 days of the vestibular disorder.
3. RIDTON (active ingredient: Rivastigmine 1.5 mg) offers significant advantages in the treatment of dementia caused by Alzheimer’s and Parkinson’s disease:
- Dual cholinesterase inhibition (AchE & BuChE)
- BROAD INDICATIONS: treatment of dementia caused by Alzheimer’s and Parkinson’s disease
- Rivastigmine improves daily living activities and overall function
- No interactions with drugs metabolized by CYP450


The presentation drew significant interest and praise from the doctors regarding the LERFOZI – FLIBGA – RIDTON products.
At the conclusion of the session, the company expressed its gratitude and hope to continue partnering with the hospital in providing effective solutions to enhance the quality of patient care. Medbolide Pharmaceutical JSC is proud to be a trusted partner of Military Central Hospital in supplying high-quality, effective medical products that contribute to the healthcare of the people.